These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1445735)

  • 1. Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party.
    Cuzick J; Allen D; Baum M; Barrett J; Clark G; Kakkar V; Melissari E; Moniz C; Moore J; Parsons V
    Eur J Cancer; 1992; 29A(1):15-21. PubMed ID: 1445735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer.
    Ingram D
    Aust N Z J Surg; 1990 Sep; 60(9):673-5. PubMed ID: 2396945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term adjuvant therapy with tamoxifen: effects on sex hormone binding globulin and antithrombin III.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Aug; 47(16):4517-9. PubMed ID: 3607780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen, serum lipoproteins and cardiovascular risk.
    Bruning PF; Bonfrer JM; Hart AA; de Jong-Bakker M; Linders D; van Loon J; Nooyen WJ
    Br J Cancer; 1988 Oct; 58(4):497-9. PubMed ID: 3207604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer.
    Fornander T; Rutqvist LE; Wilking N; Carlström K; von Schoultz B
    Eur J Cancer; 1993; 29A(4):497-500. PubMed ID: 8435199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels.
    Bertelli G; Pronzato P; Amoroso D; Cusimano MP; Conte PF; Montagna G; Bertolini S; Rosso R
    Breast Cancer Res Treat; 1988 Dec; 12(3):307-10. PubMed ID: 3228593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis.
    Pemberton KD; Melissari E; Kakkar VV
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):935-42. PubMed ID: 8148487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia.
    Nóvoa FJ; Boronat M; Carrillo A; Tapia M; Díaz-Cremades J; Chirino R
    Horm Res; 2002; 57(5-6):187-91. PubMed ID: 12053091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain.
    Caleffi M; Fentiman IS; Clark GM; Wang DY; Needham J; Clark K; La Ville A; Lewis B
    J Endocrinol; 1988 Nov; 119(2):335-9. PubMed ID: 3199064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.
    Fornander T; Rutqvist LE; Sjöberg HE; Blomqvist L; Mattsson A; Glas U
    J Clin Oncol; 1990 Jun; 8(6):1019-24. PubMed ID: 2189951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
    Decensi A; Robertson C; Viale G; Pigatto F; Johansson H; Kisanga ER; Veronesi P; Torrisi R; Cazzaniga M; Mora S; Sandri MT; Pelosi G; Luini A; Goldhirsch A; Lien EA; Veronesi U
    J Natl Cancer Inst; 2003 Jun; 95(11):779-90. PubMed ID: 12783932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
    Gylling H; Pyrhönen S; Mäntylä E; Mäenpää H; Kangas L; Miettinen TA
    J Clin Oncol; 1995 Dec; 13(12):2900-5. PubMed ID: 8523053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
    Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
    Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
    Wayne S; Neuhouser ML; Ulrich CM; Koprowski C; Wiggins C; Baumgartner KB; Bernstein L; Baumgartner RN; Gilliland F; McTiernan A; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3224-32. PubMed ID: 18957523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
    Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
    J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.